Brought to you by:
-
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of scientific advance
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they laid bare the blood, sweat and tears shed on their journey to complete the landmark study. The headline findings that emerged out of the trial—that both open and endovascular procedures were…
-
Generational divide: Do baby boomers and millennials see eye-to-eye on vascular surgery training needs?
Older-generation vascular surgeons are keen to hone their endovascular skills, while the younger generation are looking to develop their capacity to treat aortic pathologies—but surgeons at all stages in their career favor hands-on learning to continue their development. These are among the key findings of a multi-generational survey of Mexican vascular surgeons, intended to gain…
-
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled trials (RCTs). There was general agreement that the strategies are complementary, and that “picking the right thing for the right patient at the right time” should take precedence. First to speak…
-
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address. From 11:00 a.m.–12:15 p.m. in Potomac A/B, Dalsing will chart his personal journey from “small-town boy with some big dreams” to president of the SVS, as well as the history of the Society…
-
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements irrespective of baseline depression. These findings were presented during the Plenary Session 1: William J. von Liebig Forum at VAM 2023 by Bahaa Succar, MD, a postdoctoral research fellow at the…
-
The global burden of CLTI: ESVS President points toward need for new global vascular guidelines
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening talk on the World Federation of Vascular Societies (WFVS) Educational Session docket. Looking at the global burden of chronic limb-threatening ischemia (CLTI) and the joint guidelines that steer practice, Philippe Kolh,…
-
SVS-VESS@VAM 2023: Observational study addresses ‘ongoing debate’ around intervention in asymptomatic carotid patients
Alessandro Gregio, MD, a vascular surgery trainee at the University of Bologna in Bologna, Italy, presented midterm results from the Carotid asymptomatic stenosis observational study during the first of two SVS-VESS (Vascular and Endovascular Surgery Society) Scientific Sessions yesterday afternoon. “Whether to intervene or to follow [asymptomatic] patients with best medical therapy is an ongoing…
-
Cross-specialty approach to embolization ‘provides the best care for patients’
Shang Loh, MD, is chief of vascular surgery and endovascular therapy at Penn Presbyterian Medical Center in Philadelphia and professor of clinical surgery at the University of Pennsylvania. Ahead of the Embolization for Vascular Surgeons: Techniques, Tips and Tricks lunch session Wednesday (12:30–1:30pm in Maryland A), he spoke to VS@VAM about the embolization-related challenges vascular…
-
Trainees and students anticipate VAM experience
VAM brings together not only vascular surgeons but also residents, fellows and medical students keen to glean as much vascular education as possible. VS@VAM caught up with a selection of aspiring surgeons to find out how their conference was going so far—and what they hope to gain from it.
-
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD, anticipated an informative session on deep vein thrombosis (DVT) at lunchtime Wednesday. The two surgeons co-moderated Bringing What’s New in Deep Venous Thrombosis Treatments to You in 2023, from 12:30–1:30 p.m.…